Takeda Pharmaceutical Co Ltd  

(Public, TYO:4502)   Watch this stock  
Find more results for 4502
4,547.00
+1.00 (0.02%)
Apr 18 - Close
TYO data delayed by 20 mins - Disclaimer
Currency in JPY
Range 4,525.00 - 4,560.00
52 week 4,180.00 - 5,520.00
Open 4,542.00
Vol / Avg. 1.17M/3.42M
Mkt cap 3.59T
P/E 34.78
Div/yield 90.00/3.96
EPS 130.73
Shares 789.47M
Beta     -
Inst. own     -
May 8, 2014
Full Year 2014 Takeda Pharmaceutical Co Ltd Earnings and Mid-Range Growth Strategy Presentation (Japanese) - 3:30PM GMT+9 - Add to calendar
May 8, 2014
Full Year 2014 Takeda Pharmaceutical Co Ltd Earnings Release - 3:00PM GMT+9 - Add to calendar
Apr 2, 2014
Takeda Pharmaceutical Co Ltd Appointment of New COO Conference (Japanese)
Mar 10, 2014
Takeda Pharmaceutical Co Ltd at EBD BIO-Europe Spring
Mar 3, 2014
Takeda Pharmaceutical Co Ltd at Daiwa Investment Conference Tokyo
Feb 24, 2014
Takeda Pharmaceutical Co Ltd at CLSA Japan Forum
Feb 5, 2014
Q3 2014 Takeda Pharmaceutical Co Ltd Earnings Conference Call (Japanese)
Feb 5, 2014
Q3 2014 Takeda Pharmaceutical Co Ltd Earnings Conference Call
Feb 5, 2014
Q3 2014 Takeda Pharmaceutical Co Ltd Earnings Release
  

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 10.47% 8.58%
Operating margin 14.26% 5.26%
EBITD margin - 20.78%
Return on average assets 4.44% 3.55%
Return on average equity 7.96% 6.29%
Employees 30,481 -
CDP Score - 79 C

Address

4-1-1, Dosho-machi, Chuo-ku
OSAKA-SHI, OSK 540-8645
Japan
+81-6-62042111 (Phone)
+81-6-62042880 (Fax)

Website links

External links

Description

Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. The Company operates in three business segments. The Ethical Pharmaceutical segment is engaged in the manufacture and sale of pharmaceutical products, such as therapeutic substances for diabetes, circulatory drugs, anticancer drugs, drugs for central neurological diseases, digestive system drugs, hormonal agents, osteoporosis drugs, antibiotic agents, allergy medications, vitamin drops and vaccines, among others. The Healthcare segment manufactures and sells general drugs and medicines, as well as quasi drugs. The Others segment is involved in the manufacture and sale of reagents, clinical diagnostics and chemical products.

Officers and directors

Yasuchika Hasegawa President, Representative Director
Age: 67
Frank Morich Chief Commercial Officer, President of Subsidiary, Director
Age: 59
Tadataka Yamada Chief Medical and Scientific Officer, Director
Age: 68
Yasuhiko Yamanaka Managing Director
Age: 57
Masato Iwasaki Chief Director of Pharmaceutical Sales, Director
Age: 54
Shinji Honda Director of Business Planning, Director
Age: 55
Yorihiko Kojima Independent Director
Age: 71
Fumio Sudo Independent Director
Age: 72